| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.005 |